Disease | hematopoietic stem cell transplantation |
Phenotype | C0011847|diabetes |
Sentences | 2 |
PubMedID- 26391893 | For the patients who received rituximab-containing chemotherapy, the risk factors included female gender, diabetes mellitus, multiple courses of chemotherapy, autologous hematopoietic stem cell transplantation and higher accumulated rituximab dose. |
PubMedID- 22093891 | Objective: to explore the efficacy and safety of autologous peripheral blood hematopoietic stem cell transplantation (apbhst) in patients with type 1 diabetes mellitus. |
Page: 1